NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, San Diego
Regeneron Pharmaceuticals
Intensity Therapeutics, Inc.
Atara Biotherapeutics
Hoosier Cancer Research Network
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC